Karthika Anoop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Karthika Anoop has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Anilakumar Kandangath Raghavan
2 shared publicationsKowmudi Gullapalli
2 shared publicationsKrishnaveni Nagappan
2 shared publicationsSreenath Konanki
2 shared publications- Bhaskar PhanindraSharma
Center of Excellence in Molecular Biology and Regenerative Medicine (CEMR) Laboratory, Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education & Research, Mysore 570015, Karnataka, India
1 shared publication - Dugganaboyana Guru Kumar
Division of Biochemistry, School of Life Sciences, Mysuru, JSS Academy of Higher Education & Research, Mysore 570015, Karnataka, India
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Phytochemical-rich fraction from raw and cooked kodo millet ( Paspalum scrobiculatum L.) reduced the viability of colorectal- and breast cancer cells in vitro by inducing apoptosis
Bioactivity-guided fractionation identified KM75 as the most potent KMR fraction. KM75 induced apoptosis, DNA fragmentation and reduced intracellular ROS in breast cancer cells, supporting further in vitro / in vivo evaluation.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Open AccessPhytochemical-rich fraction from raw and cooked kodo millet ( Paspalum scrobiculatum L.) reduced the viability of colorectal- and breast cancer cells in vitro by inducing apoptosis
Bioactivity-guided fractionation identified KM75 as the most potent KMR fraction. KM75 induced apoptosis, DNA fragmentation and reduced intracellular ROS in breast cancer cells, supporting further in vitro / in vivo evaluation.
- 3 May 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (6) , e70098
Design of Experiments Approach for the Development of a Validated UPLC‐Q‐ToF/MS Method to Quantitate Soy‐Derived Bioactive Peptide Lunasin in Rabbit Plasma: Application to a Pharmacokinetic Study
A novel ultraperformance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometric (UPLC‐Q‐ToF/MS) method for quantifying soy‐derived bioactive peptide lunasin in rabbit plasma was developed using design of experiments (DoE) methodology. Lunasin and Neuropeptide Y as an internal standard (IS) were separated on a BEH‐C18 column (50 mm × 2.1 mm, 1.7 μm particle size) using 0.1% formic acid solution and acetonitrile as mobile phase delivered for 9 min at a constant flow rate of 0.4 mL/min in gradient mode. The Q‐ToF mass spectrometer, equipped with electrospray combined ionization (ESCi) interface, was operated in positive ion mode, and the quantifier ions of lunasin and IS were at m/z 838 and m/z 602, respectively. The lower limit of quantification (LLOQ) was 34.6 ng/mL, and the assay was linear over the concentration range 35–10,000 ng/mL. The accuracy was within a range from 86.7% to 88.9% in terms of mean recovery (R), and the intraday and interday precisions in terms of relative standard deviation (RSD) were < 2.65% and < 6.22%, respectively. The method was successfully applied to a pharmacokinetic study involving oral administration of lunasin‐rich processed soybeans (6.56 and 19.1 g/kg) to rabbits.
- 3 May 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (6) , e70098
Design of Experiments Approach for the Development of a Validated UPLC‐Q‐ToF/MS Method to Quantitate Soy‐Derived Bioactive Peptide Lunasin in Rabbit Plasma: Application to a Pharmacokinetic Study
A novel ultraperformance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometric (UPLC‐Q‐ToF/MS) method for quantifying soy‐derived bioactive peptide lunasin in rabbit plasma was developed using design of experiments (DoE) methodology. Lunasin and Neuropeptide Y as an internal standard (IS) were separated on a BEH‐C18 column (50 mm × 2.1 mm, 1.7 μm particle size) using 0.1% formic acid solution and acetonitrile as mobile phase delivered for 9 min at a constant flow rate of 0.4 mL/min in gradient mode. The Q‐ToF mass spectrometer, equipped with electrospray combined ionization (ESCi) interface, was operated in positive ion mode, and the quantifier ions of lunasin and IS were at m/z 838 and m/z 602, respectively. The lower limit of quantification (LLOQ) was 34.6 ng/mL, and the assay was linear over the concentration range 35–10,000 ng/mL. The accuracy was within a range from 86.7% to 88.9% in terms of mean recovery (R), and the intraday and interday precisions in terms of relative standard deviation (RSD) were < 2.65% and < 6.22%, respectively. The method was successfully applied to a pharmacokinetic study involving oral administration of lunasin‐rich processed soybeans (6.56 and 19.1 g/kg) to rabbits.
- 8 November 2022
- Published by Springer Nature in Journal of Food Measurement and Characterization
- Vol. 17 (1) , 944-955
Optimization of ultrasonication-assisted extraction conditions using RSM-I-Optimal experimental design to recover vitamin D2 and K1 from selected green leafy vegetable samples
This study employed the response surface methodology to optimize the extraction conditions for recovering vitamins D2 and K1 from green leafy vegetables using ultrasonication-assisted extraction. The vitamin content was determined using an Accucore C18 column and a UPLC-Q-ToF/MS method. An RSM-I-Optimal design was used for designing the experiment to find the best combination of solvent level (mL), sonication time (min), sonication frequency (kHz), and temperature (°C). The experimental data from a 25-sample set were fitted to a second-order polynomial equation using multiple regression analysis. The extraction models had R2 values of 0.895 and 0.896, respectively, and the probability values (p < 0.0001) indicated that the regression model was highly significant. The optimal extraction conditions were: solvent level of 65 mL, sonication time of 45 min, sonication frequency of 70 kHz, and temperature of 45 °C. Under these conditions, the predicted recovery (%) values for vitamins D2 and K1 were 90.7% and 90.4%, respectively. This study has the potential to use the reported extraction method for routine quantification of vitamins D2 and K1 in the laboratory using UPLC-Q-ToF/MS.
- 8 November 2022
- Published by Springer Nature in Journal of Food Measurement and Characterization
- Vol. 17 (1) , 944-955
Optimization of ultrasonication-assisted extraction conditions using RSM-I-Optimal experimental design to recover vitamin D2 and K1 from selected green leafy vegetable samples
This study employed the response surface methodology to optimize the extraction conditions for recovering vitamins D2 and K1 from green leafy vegetables using ultrasonication-assisted extraction. The vitamin content was determined using an Accucore C18 column and a UPLC-Q-ToF/MS method. An RSM-I-Optimal design was used for designing the experiment to find the best combination of solvent level (mL), sonication time (min), sonication frequency (kHz), and temperature (°C). The experimental data from a 25-sample set were fitted to a second-order polynomial equation using multiple regression analysis. The extraction models had R2 values of 0.895 and 0.896, respectively, and the probability values (p < 0.0001) indicated that the regression model was highly significant. The optimal extraction conditions were: solvent level of 65 mL, sonication time of 45 min, sonication frequency of 70 kHz, and temperature of 45 °C. Under these conditions, the predicted recovery (%) values for vitamins D2 and K1 were 90.7% and 90.4%, respectively. This study has the potential to use the reported extraction method for routine quantification of vitamins D2 and K1 in the laboratory using UPLC-Q-ToF/MS.
- 1 February 2022
- Published by Elsevier in Current Pharmaceutical Analysis
- Vol. 18 (2) , 228-239
Ultra-Performance Liquid Chromatography Coupled with a Triple Quadrupole Mass Spectrometric Method for the Quantification of Antiepileptic Drugs Methsuximide and Normesuximide in Human Plasma and its Application in a Pharmacokinetic Study
Background: Extensive therapeutic drug monitoring needs an analytical method for efficient and sensitive quantification of analytes of interest in clinical pharmacology. Objective: A rapid, robust, sensitive and simple UPLC-MS/MS method to quantify Methsuximide (Ms) and N-desmethyl methsuximide/Normesuximide (MsMET) in human plasma was optimized, developed, and validated for application in a pharmacokinetic study. Method: Reverse phased chromatography was performed using Zorbax SB-C18, 4.6 x 75 mm., 3.5 μm as stationary phase, methanol and 0.1% formic acid (60:40 v/v) as mobile phase which was delivered isocratically at a flow rate of 0.9 mL/min. The sample injection volume was 5 μL. Mass spectrometric quantification of the analytes was performed using positive electrospray ionization as mass interface along with multiple reaction monitoring (MRM) as acquisition mode. Results: The selected mass transition ions for analyte, metabolite and its respective internal standards are as follows, precursor ion (m/z) and product ion (m/z): Ms (204.06 and 119.02), MsMET (190.05 and 119.82), Ms internal standard (MsIS) (209.17 and 124.02), and MsMET internal standard (MsMETIS) (195.09 and 124.16), respectively. The current method was found to be linear for Ms (60.720-6043.800 ng/mL) and MsMET (60.389 - 6010.800 ng/mL) with r2 values not less than 0.999. The mean recoveries of all analytes ranged between 71.37 and 86.38 percentage. Conclusion: This method was validated in accordance with USFDA’s bioanalytical guidelines. Conclusion: This method was validated in accordance with USFDA’s bioanalytical guidelines. This method could be applied for a routine analysis of Ms and MsMET in clinical pharmacological practice.
- 1 February 2022
- Published by Elsevier in Current Pharmaceutical Analysis
- Vol. 18 (2) , 228-239
Ultra-Performance Liquid Chromatography Coupled with a Triple Quadrupole Mass Spectrometric Method for the Quantification of Antiepileptic Drugs Methsuximide and Normesuximide in Human Plasma and its Application in a Pharmacokinetic Study
Background: Extensive therapeutic drug monitoring needs an analytical method for efficient and sensitive quantification of analytes of interest in clinical pharmacology. Objective: A rapid, robust, sensitive and simple UPLC-MS/MS method to quantify Methsuximide (Ms) and N-desmethyl methsuximide/Normesuximide (MsMET) in human plasma was optimized, developed, and validated for application in a pharmacokinetic study. Method: Reverse phased chromatography was performed using Zorbax SB-C18, 4.6 x 75 mm., 3.5 μm as stationary phase, methanol and 0.1% formic acid (60:40 v/v) as mobile phase which was delivered isocratically at a flow rate of 0.9 mL/min. The sample injection volume was 5 μL. Mass spectrometric quantification of the analytes was performed using positive electrospray ionization as mass interface along with multiple reaction monitoring (MRM) as acquisition mode. Results: The selected mass transition ions for analyte, metabolite and its respective internal standards are as follows, precursor ion (m/z) and product ion (m/z): Ms (204.06 and 119.02), MsMET (190.05 and 119.82), Ms internal standard (MsIS) (209.17 and 124.02), and MsMET internal standard (MsMETIS) (195.09 and 124.16), respectively. The current method was found to be linear for Ms (60.720-6043.800 ng/mL) and MsMET (60.389 - 6010.800 ng/mL) with r2 values not less than 0.999. The mean recoveries of all analytes ranged between 71.37 and 86.38 percentage. Conclusion: This method was validated in accordance with USFDA’s bioanalytical guidelines. Conclusion: This method was validated in accordance with USFDA’s bioanalytical guidelines. This method could be applied for a routine analysis of Ms and MsMET in clinical pharmacological practice.